Back to Authors

Beaudet, Arthur L.

https://orcid.org/0000-0003-2083-3192

Mayo Clinic

Baylor College of Medicine

Citations 1

Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data
Nambot, Sophie , Gavrilov, Dimitar , Thévenon, Julien , Bruel, Ange‐Line , Bainbridge, Matthew N. , Rio, Marlène , Goizet, Cyril , Rötig, Agnès , Jaeken, J., Niu, N., Xia, Fan , Vital, Anne, Houcinat, Nada, Mochel, Fanny , Kuentz, Paul , Lehalle, Daphné , Duffourd, Yannis , Rivière, Jean‐Baptiste , Thauvin-Robinet, Christel, Beaudet, Arthur L. , Faivre, Laurence , Nambot, S , Thevenon, J , Thauvin‐Robinet, Christel , Faivre, Laurence

Clinical Genetics | February 3, 2017 | Volume: 92 | Issue: 2 | Pages: 188-198

10.1111/cge.12985 Get It

BackgroundAlterations in GFER gene have been associated with progressive mitochondrial myopathy, congenital cataracts, hearing loss, developmental delay, lactic acidosis and respiratory chain deficiency in 3 siblings born to consanguineous Moroccan parents by homozygosity mapping and candidate gene approach (OMIM#613076). Next generation sequencing recently confirmed this association by the finding of compound heterozygous variants in 19‐year‐old girl with a strikingly similar phenotype, but this ultra‐rare entity remains however unknown from most of the scientific community.Materials and MethodsWhole exome sequencing was performed as part of a “diagnostic odyssey” for suspected mitochondrial condition in 2 patients, presenting congenital cataracts, progressive encephalomyopathy and hypotrophy and detected unreported compound heterozygous variants in GFER.ResultsThanks to an international data sharing, we found 2 additional patients carrying compound heterozygous variants in GFER. Reverse phenotyping confirmed the phenotypical similarities between the 4 patients. Together with the first literature reports, the review of these 8 cases from 4 unrelated families enables us to better describe this apparently homogeneous disorder, with the clinical and biological stigmata of mitochondrial disease.ConclusionThis report highlights the clinical utility of whole exome sequencing and reverse phenotyping for the diagnosis of ultra‐rare diseases and underlines the importance of a broad data sharing for accurate clinical delineation of previously unrecognized entities.